Company
Headquarters: Melbourne, VIC, Australia
Employees: 1,524
CEO: Dr. Ian Kadish M.B.A., MBBCh, MBA
A$628.7 Million
AUD as of July 1, 2024
US$418.7 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company provides its services through 67 radiology clinics. Integral Diagnostics Limited was incorporated in 2008 and is headquartered in Melbourne, Australia.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | June 30, 2023 |
| Revenue TTM | A$456.3 M |
| EBITDA | A$92.5 M |
| Gross Profit TTM | A$419.1 M |
| Profit Margin | -12.68% |
| Operating Margin | 8.61% |
| Quarterly Revenue Growth | 7.20% |
Integral Diagnostics Limited has the following listings and related stock indices.
Stock: ASX: IDX wb_incandescent